Net Loss per Share Attributable to Common and Limited Common Stockholders - Schedule of Potentially Dilutive Securities not Included in Diluted Per Share Calculations Anti-dilutive (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) | 15,657,787 | 15,251,426 |
| Employee Stock Option | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) | 12,395,566 | 12,696,887 |
| RSUs and PRSUs | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) | 3,262,221 | 2,554,539 |